Cell Signaling and Signal Transduction

Course Administration and Video Project Specifications

• Upcoming Examination Details:

  • The examination is scheduled exactly one week away.

  • Covered topics include proteins, transcription, translation, regulation of transcription and translation, the cell cycle, and cell signaling.

• Video Project Assignment Overview:

  • Core Objective: Select a specific transcription factor identified as a common contributor to cancerous phenotypes and produce an instructional video tutorial.

  • Reference Literature: The review paper by Vishnoy et al. serves as a primary guide; Table 1 of this publication provides a list of candidate transcription factors, including $\text{HIF-1}\tau$ (hypoxia-inducible factor 1-alpha) and $p53$.

  • Mechanistic Explanations Required:

  • Describe how the selected transcription factor functions within healthy cells.

  • Detail the specific molecular dysfunctions that contribute to a cancerous phenotype.

  • Therapeutic Component:

  • Consult Table 2 and Table 3 of the Vishnoy et al. paper to identify a therapeutic drug that is either currently in clinical trials or approved and available on the market.

  • Explain how the drug functions at the molecular level to counteract or rectify the dysfunction caused by the chosen transcription factor.

  • Source and Citation Requirements:

  • Exactly five sources must be utilized.

  • One source must be the paper by Vishnoy et al.

  • The remaining four sources may consist of primary literature, secondary literature, or tertiary literature.

  • A works cited slide using a consistent citation style is mandatory.

  • An Artificial Intelligence (AI) transparency statement must be included.

  • Presentation Format and Technical Requirements:

  • Presenters must physically appear on camera; voice-only or strictly behind-the-scenes narration is not permitted.

  • Format options are flexible, ranging from skits (comparable to the Massachusetts Institute of Technology [MIT] teaching assistant presentations on the lac operon) to voice-over slide decks featuring an on-camera presenter.

  • The presentation duration must be exactly four minutes long.

  • The video must be completely free of factual errors.

  • Evaluation Rubric:

  • The primary grading criterion is content accuracy and depth.

  • The student must accurately identify and thoroughly describe the cellular processes occurring in both healthy and diseased states.

  • The chosen cancer therapy must target the identified cellular dysfunction, and its precise mechanism of action must be fully articulated.

  • Submission Deadline: The project is due on the final day of class.

Principles of Intercellular Communication

• Environmental Control of Gene Expression:

  • The localization and movement of specific transcription factors into the nucleus establish distinct regulatory environments.

  • The specific combination of transcription factors active within the nucleus is dictated by signals received from the cellular environment.

  • Multicellular eukaryotic organisms (such as humans) rely on intricate cell communication networks to coordinate cellular activities and tissue homeostasis.

• Modes of Cell Signaling Based on Distance:

  • Endocrine Signaling:

  • Operates over the longest physical distances.

  • Signaling cells synthesize and release endocrine molecules (hormones) directly into the bloodstream.

  • Blood-borne transport enables the signal to circulate systemically, simultaneously influencing multiple organ systems (such as the muscular system, gastrointestinal tract, and integumentary system).

  • Any target tissue whose cells express the specific receptor can detect and respond to the circulating signal.

  • Paracrine and Autocrine Signaling:

  • Operates locally over distances spanning a few cell diameters within a single tissue.

  • Paracrine signaling involves a cell secreting signaling ligands into the extracellular fluid to act on neighboring target cells.

  • Autocrine signaling occurs when a cell releases a signaling ligand that binds to receptors located on its own surface.

  • Contact-Dependent (Juxtacrine) Signaling:

  • Requires physical contact between adjacent cells.

  • The signaling molecule is not secreted into the extracellular space; instead, it remains an integral transmembrane protein embedded within the plasma membrane of the signaling cell and binds directly to a receptor on the membrane of an adjacent cell.

  • Neuronal Signaling:

  • A specialized form of local communication occurring between immediately adjacent cells.

  • Neurotransmitter ligands are exocytosed from the signaling presynaptic cell and diffuse across a narrow intercellular gap known as the synaptic cleft to bind receptors on the postsynaptic target cell.

• Pathology of Miscommunication in Cancer:

  • Cancer frequently emerges from the breakdown of normal intercellular signaling.

  • Cells may receive inappropriate or continuous pro-growth signals in the absence of physiological need, leading to uncontrolled proliferation and the acquisition of a cancerous phenotype.

Signal Types and Receptor Localization

• Signal Classification and Biochemical Properties:

  • Protein and Peptide Signals: Large, polar, and amphipathic molecules that cannot cross the hydrophobic lipid bilayer of the cell membrane.

  • Lipid Signals: Small, rigid, and hydrophobic/nonpolar molecules that readily diffuse directly through the plasma membrane.

  • Examples derived from cholesterol modification include cortisol, estradiol, and testosterone.

  • An example of a non-cholesterol-derived lipid-soluble signaling hormone is thyroxine.

  • Dissolved Gas Signals: Small dissolved gases, most notably nitric oxide ($\text{NO}$), serve as specialized signaling molecules capable of direct membrane diffusion.

• Receptor Characteristics and Cellular Competence:

  • Receptors are always proteins.

  • The ability of a cell to detect an extracellular signal depends entirely on whether it expresses the cognate receptor protein.

  • A cell that expresses the receptor is defined as competent to the signal.

  • If a cell lacks the receptor, it is completely insensitive to the signal regardless of extracellular concentration.

  • The presence or absence of a receptor in a target cell is governed by gene expression.

• Receptor Biosynthesis and Cellular Subcellular Localization:

  • Cell-Surface (Transmembrane) Receptors:

  • Bind protein/peptide ligands that cannot penetrate the bilayer.

  • Synthesized on ribosomes docked at the rough endoplasmic reticulum (RER), integrated into the RER membrane, and trafficked to the cell surface.

  • Intracellular (Cytoplasmic) Receptors:

  • Bind lipid ligands that diffuse across the plasma membrane.

  • Synthesized by free ribosomes operating within the cytoplasm.

  • Float freely in the cytoplasm until activated by ligand binding (e.g., the cytoplasmic cortisol receptor and testosterone receptor).

• Structural Domains of Transmembrane Protein Receptors:

  • Extracellular Domain: Faces the extracellular space and functions as the ligand-binding domain, featuring a stereospecific conformation designed to interact with the signaling molecule.

  • Transmembrane Domain: Spans the interior of the phospholipid bilayer, adopting a stable alpha-helical structural conformation.

  • Intracellular Domain: Extends into the cytosol; functions either as an enzymatic/catalytic domain (such as an intrinsic kinase) or as a molecular scaffold that coordinates the recruitment of downstream intracellular proteins.

Mechanisms of Cell Surface Receptor Activation and Signal Integration

• Signal Relay Across the Bilayer:

  • Extracellular protein ligands never physically enter the cytoplasm.

  • The interaction between the ligand and the extracellular domain induces a conformational change that propagates through the transmembrane domain to alter the shape and function of the intracellular domain.

  • This structural rearrangement translates the external binding event into an intracellular biochemical signal.

• Constitutive Receptor Activation and Proto-Oncogenes:

  • Genetic mutations can alter the structure of a transmembrane receptor such that it remains permanently locked in an active ("always on") state, independent of ligand presence.

  • Cells bearing constitutively active growth factor receptors interpret the persistent activation as an instruction to continually divide.

  • Signaling proteins that promote cell proliferation when overactive represent proto-oncogenes; gain-of-function mutations convert them into oncogenes that drive tumorigenesis.

  • Signaling breakdowns contributing to cancer occur via three main mechanisms: overproduction of the signaling ligand, constitutive or illegitimate activation of the receptor, or hyperactive transduction of the signal along intracellular pathways.

• Cellular Context and Pleiotropic Signaling:

  • The ultimate cellular outcome triggered by a signaling molecule depends on the internal biochemical machinery and proteomic context of the target cell, rather than the ligand alone.

  • The same neurotransmitter, acetylcholine, interacting with its cognate receptor induces entirely different responses across tissues:

  • Heart Muscle Cells: Causes a decrease in the rate and force of contraction.

  • Salivary Gland Cells: Stimulates the exocytosis and secretion of salivary enzymes.

  • Skeletal Muscle Cells: Causes an increased rate of contraction.

• Combinatorial Signaling Networks:

  • Eukaryotic cells continuously monitor combinations of signals to dictate cell fate:

  • Survival Signals: Basal combinations (such as Signals A, B, and C) maintain cell viability.

  • Growth and Division: The addition of mitogenic/growth signals (Signals D and E) alongside survival signals instructs the cell to undergo growth and division.

  • Differentiation Signals: Replacing growth factors with differentiation cues directs the cell to adopt a specialized cellular lineage.

  • Apoptosis: Deprivation of essential survival signals triggers programmed cell death (apoptosis).

• Temporal Dynamics of Signal Transduction:

  • Fast Response:

  • Operates on the scale of seconds to minutes.

  • Signal reception directly modifies pre-existing cytoplasmic proteins or enzymes via post-translational modifications (e.g., phosphorylation).

  • Slow Response:

  • Operates on the scale of hours.

  • Signal transduction culminates in the translocation of specific transcription factors into the nucleus to direct gene transcription and protein translation, creating brand new proteins.

  • Example of Slow Response ($\text{HIF-1}\alpha$ Regulation):

    • Hypoxia-inducible factor 1-alpha ($\text{HIF-1}\alpha$) is constitutively expressed in the cytoplasm.

    • Under high oxygen tension (normoxia), $\text{HIF-1}\alpha$ is targeted for continuous enzymatic degradation.

    • Under low oxygen tension (hypoxia), $\text{HIF-1}\alpha$ stabilizes, translocates into the nucleus, binds DNA cis-elements called enhancers, and upregulates the transcription of glucose transporter 1 ($\text{GLUT1}$) and pyruvate dehydrogenase kinase 1 ($\text{PDK1}$) repressors.

• Mechanistic Differences Between Lipid and Protein Signaling:

  • Lipid Signaling (Universal Mechanism):

  • Lipid hormone diffuses through the plasma membrane and binds its cytoplasmic receptor.

  • Conformational change allows the activated hormone-receptor complex to translocate into the nucleus.

  • The complex acts as a specific transcription factor, binding to enhancer cis-regulatory elements to upregulate gene transcription.

  • Operates strictly and universally as a transcriptional regulator; does not amplify signals cytoplasmically or modify pre-existing machinery directly.

  • Protein Signaling:

  • Can alter pre-existing metabolic enzymes (altering metabolism).

  • Can alter cytoskeletal proteins (altering cell shape, motility, or spindle assembly).

  • Can alter specific transcription factors (modifying gene expression).

• Core Functions of Cell-Surface Receptors:

  • Relay: Transmitting the message from outside the cell across the membrane.

  • Amplify: Generating vast numbers of intracellular secondary messengers or activating cascades of enzymes so that a single ligand produces a large cytoplasmic response.

  • Integrate: Merging inputs from several distinct signaling pathways into a unified cellular output.

Receptor Tyrosine Kinases and the Ras Molecular Switch

• Three Major Classes of Cell Surface Receptors:

  • Ion channel-coupled (gated) receptors.

  • G-protein coupled receptors (GPCRs).

  • Enzyme-coupled receptors.

• Molecular Switching Mechanisms:

  • Phosphorylation/Dephosphorylation (Kinases and Phosphatases):

  • A post-translational modification where a protein kinase transfers a terminal phosphate group from $\text{ATP}$ to a specific amino acid side chain, shifting the protein into an active ("on") conformation.

  • A protein phosphatase hydrolyzes and removes the phosphate group, restoring the basal ("off") conformation.

  • Tyrosine kinases selectively phosphorylate the hydroxyl group of tyrosine residues, whereas serine/threonine kinases phosphorylate serines and threonines.

  • GTP/GDP Nucleotide Switches:

  • Guanine nucleotide-binding proteins are inactive ("off") when bound to guanosine diphosphate ($\text{GDP}$).

  • Signal reception stimulates the displacement of $\text{GDP}$ and the recruitment of guanosine triphosphate ($\text{GTP}$), inducing an active ("on") conformation that acts on downstream targets.

  • The protein turns off when intrinsic or assisted GTPase activity hydrolyzes $\text{GTP}$ back to $\text{GDP}$.

• Receptor Tyrosine Kinase (RTK) Dimerization and Transphosphorylation:

  • In the absence of ligand, RTKs (such as the Epidermal Growth Factor [EGF] receptor) exist predominantly as inactive monomers that diffuse laterally within the lipid bilayer.

  • Monomers collide spontaneously and reversibly, but associations remain unstable unless stabilized by ligand binding.

  • Binding of the extracellular ligand (e.g., $\text{EGF}$) stabilizes the association of two adjacent receptor monomers into a functional dimer.

  • Dimerization brings the intracellular kinase domains into proximity, initiating transphosphorylation (reciprocal auto-phosphorylation):

  • The kinase domain of one subunit phosphorylates tyrosine residues on the cytoplasmic tail of the partner subunit, and vice versa.

  • The resulting clusters of phosphorylated tyrosines serve as high-affinity docking sites for specific intracellular adaptor and scaffolding proteins.

• The Small Monomeric GTPase Ras:

  • Ras is a membrane-associated monomeric GTPase that acts as an essential molecular switch downstream of most RTKs.

  • Ras is one of the most frequently mutated proto-oncogenes in human malignancies.

  • Activation Cycle:

  • Resting Ras is bound to $\text{GDP}$ in an inactive state.

  • Phosphorylated RTKs recruit cytoplasmic adaptor proteins that bind a Guanine Nucleotide Exchange Factor (GEF, historically termed GRAS activating protein).

  • GEF displaces $\text{GDP}$ from Ras, facilitating the binding of cytosolic $\text{GTP}$.

  • Ras-$\text{GTP}$ adopts an active conformation capable of binding downstream effectors.

  • Over time, a GTPase-Activating Protein (GAP) stimulates Ras to hydrolyze its bound $\text{GTP}$ into $\text{GDP}$ and inorganic phosphate ($\text{P}_i$), returning Ras to its inactive state.

  • Oncogenic Gain-of-Function:

  • Mutations that impair the intrinsic GTPase activity of Ras or prevent its interaction with GAP lock Ras into a constitutively active state.

  • Constitutively active Ras persistently transmits pro-mitotic signals through the cytoplasm even in the total absence of upstream extracellular growth factors.

The MAP Kinase (MAPK) Signaling Cascade and Cellular Outcomes

• Signal Relaying via the MAPK Cascade:

  • Phosphorylation of RTK tails, recruitment of adaptors, and GEF-mediated activation of Ras all occur at the inner face of the plasma membrane.

  • To communicate with the nucleus, the signal must leave the membrane and travel through the cytoplasm; this relay is mediated by the Mitogen-Activated Protein Kinase (MAPK) cascade.

  • The MAPK cascade is one of seven highly conserved intracellular signaling pathways found across eukaryotic species.

  • The pathway functions as a molecular relay race, passing activation downstream through sequential phosphorylation events:

  • Activated, membrane-bound Ras-$\text{GTP}$ binds and activates MAP kinase kinase kinase (MAPKKK).

  • Active MAPKKK phosphorylates and activates MAP kinase kinase (MAPKK).

  • Active MAPKK phosphorylates and activates MAP kinase (MAPK).

• Effector Functions of Activated MAP Kinase:

  • Once phosphorylated, active MAPK dissociates and phosphorylates various target proteins in multiple cellular compartments:

  • Cytoplasmic Targets: Phosphorylates cytoskeletal proteins to modulate cell morphology and spindle formation during mitosis, or alters metabolic enzyme rates.

  • Nuclear Envelope Targets: Phosphorylates structural lamin proteins, facilitating disassembly of the nuclear lamina during cell division.

  • Nuclear Transcription Regulators: Translocates into the nucleus to phosphorylate specific transcription factors (such as $\text{MYC}$ and $\text{ELK}$), enabling them to bind enhancers and drive transcription of genes required for cell cycle progression.

• Signal Amplification Through Kinase Cascades:

  • Unlike stoichiometric lipid signaling (where one or two hormone molecules translocate to activate single response units), kinase cascades achieve exponential geometric amplification.

  • A single activated upstream kinase can phosphorylate multiple downstream kinase substrates before returning to its basal state.

  • Each phosphorylated intermediate acts catalytically on multiple substrates at the next tier.

  • As a consequence, a single ligand-receptor binding event at the cell surface produces thousands of active downstream effector molecules within the cell.

• Signal Integration and Cellular Networks:

  • Complex cellular behaviors are governed by the simultaneous integration of multiple distinct signaling pathways converging on identical downstream regulatory hubs.

  • Surface receptors (including RTKs and GPCRs) initiate branching pathways such as the MAPK pathway, the JNK (c-Jun N-terminal kinase) pathway, and the SRC-MYC pathway.

  • These disparate pathways converge to phosphorylate and fine-tune the activity of shared transcription factors (e.g., $\text{MYC}$ and $\text{ELK}$).

  • This integration permits precise, graded regulation of cellular outcomes based on the total combination of environmental inputs.